Document is current
Any future updates will be listed below
-
Authors
Olaniran, Marianne O.
Neti, Sitapriya
Polavarapu, Dhatri
Adewunmi, Adejumoke
Francis, Jackson
Mathew, M. Sunil https://orcid.org/0000-0002-7529-2832
Schellinger, Jeffrey N.
Allicock, Marlyn A.
Messiah, Sarah E.
Almandoz, Jaime P. https://orcid.org/0000-0002-0462-0843
- License Information
-
More Information
Article History
Received: 17 December 2024
Revised: 27 October 2025
Accepted: 26 November 2025
First Online: 15 December 2025
Competing interests
: This study was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest. However, JPA has received advisory or consulting fees and/or other support from AbbVie, Boehringer Ingelheim, Eli Lilly and Company, Nestlé, Novo Nordisk A/S and Wave Life Sciences.
: All methods were performed in accordance with the relevant guidelines and regulations. This qualitative study adhered to the Standards for Reporting Qualitative Research (SRQR) guidelines for reporting qualitative research. All study procedures were approved by the Institutional Review Board (IRB) of the Committee for the Protection of Human Subjects (CPHS) at The University of Texas Health Science Center at Houston on November 5, 2018. The approval reference number is IRB NUMBER: HSC-SPH-18-0850.
: Participants were recruited following procedures approved by the IRB. Digital informed consent was obtained from all participants by clicking the embedded link within the initial communication, which directed them to a researcher-designed questionnaire where they provided consent and demographic information.
